Scarica l'app Stockscreener
80.47
2.13%
-1.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Precedente Chiudi:
$82.22
Aprire:
$81.99
Volume 24 ore:
403.73K
Relative Volume:
0.82
Capitalizzazione di mercato:
$5.36B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-20.63
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
-0.52%
1M Prestazione:
+5.04%
6M Prestazione:
+10.96%
1 anno Prestazione:
-1.48%
Intervallo 1D:
$80.13
$82.40
Intervallo di 1 settimana:
$74.40
$83.09
Portata 52W:
$55.53
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
Nome
Nuvalent Inc
Settore
Industria
Telefono
508-446-2272
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Confronta NUVL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
80.47 | 5.66B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-09-03 | Iniziato | Raymond James | Outperform |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-03-14 | Aggiornamento | UBS | Neutral → Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-24 | Iniziato | UBS | Neutral |
| 2024-08-29 | Iniziato | Barclays | Overweight |
| 2024-04-17 | Iniziato | Jefferies | Buy |
| 2024-04-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | Ripresa | Guggenheim | Buy |
| 2024-02-23 | Iniziato | Robert W. Baird | Outperform |
| 2023-09-27 | Iniziato | Stifel | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Market Perform |
| 2023-07-24 | Iniziato | Guggenheim | Buy |
| 2023-01-18 | Iniziato | Wedbush | Outperform |
| 2022-06-24 | Iniziato | BMO Capital Markets | Outperform |
Mostra tutto
Nuvalent Inc Borsa (NUVL) Ultime notizie
Nuvalent, Inc. $NUVL Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Wedbush Reaffirms "Outperform" Rating for Nuvalent (NASDAQ:NUVL) - MarketBeat
Fred Alger Management LLC Reduces Stock Position in Nuvalent, Inc. $NUVL - MarketBeat
Voleon Capital Management LP Invests $1.49 Million in Nuvalent, Inc. $NUVL - MarketBeat
Alyeska Investment Group L.P. Decreases Stock Position in Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent, Inc. $NUVL Stake Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Nuvalent (NASDAQ:NUVL) Coverage Initiated at Guggenheim - MarketBeat
Nuvalent, Inc. $NUVL Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
What makes Nuvalent Inc. stock attractive todayJuly 2025 Volume & Real-Time Volume Trigger Notifications - Lancaster City Council
Can Nuvalent Inc. grow without external fundingLong Setup & Daily Growth Stock Investment Tips - Lancaster City Council
Drawdown in Nuvalent Inc. May Be Nearing End2025 Analyst Calls & Stock Timing and Entry Methods - beatles.ru
Harpreet Singh Showcases Biotech on the Main Stage at WCLC2025 - Oncodaily
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts - MSN
Walleye Capital LLC Sells 42,253 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 - StreetInsider
Breaking Lung Cancer Treatment Advance: Nuvalent's Zidesamtinib Shows Promise in Critical NSCLC Trial - Stock Titan
Nuvalent Inc. Sees Spike in Bullish Option FlowJuly 2025 Catalysts & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Nuvalent, Inc. $NUVL is Vestal Point Capital LP's 4th Largest Position - MarketBeat
Is it too late to sell Nuvalent Inc.July 2025 Update & AI Forecast Swing Trade Picks - Newser
Can momentum traders help lift Nuvalent Inc.2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
When is the best time to exit Nuvalent Inc.Portfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Braidwell LP Has $59.64 Million Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Is Nuvalent Inc. stock forming a triangle pattern2025 Market Overview & Verified Technical Trade Signals - خودرو بانک
Is now the right time to enter Nuvalent Inc.Quarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
Market reaction to Nuvalent Inc.’s recent newsWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Is Nuvalent Inc. stock a buy or sellTreasury Yields & Weekly Watchlist for Hot Stocks - خودرو بانک
Best data tools to analyze Nuvalent Inc. stockJuly 2025 Update & Daily Entry Point Alerts - Newser
Is Nuvalent Inc.’s ROIC above industry averageJuly 2025 Big Picture & Safe Swing Trade Setups - خودرو بانک
Nuvalent, Inc. $NUVL Holdings Trimmed by Northern Trust Corp - MarketBeat
Should I buy Nuvalent Inc. stock now2025 Institutional Moves & Low Risk High Reward Ideas - خودرو بانک
Can Nuvalent Inc. navigate macro headwindsInflation Watch & Verified Short-Term Plans - 더경남뉴스
Inflation Data: Can Nuvalent Inc. navigate macro headwindsJuly 2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - khodrobank.com
Nuvalent, Inc. $NUVL is Paradigm Biocapital Advisors LP's Largest Position - MarketBeat
How moving averages guide Nuvalent Inc. tradingQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Is Nuvalent Inc. stock entering bullish territory2025 Valuation Update & Daily Chart Pattern Signal Reports - Newser
Nuvalent Inc. stock outlook for YEARMarket Trend Review & High Conviction Buy Zone Alerts - Newser
BostInnoCoconut water out, cactus water in | Nuvalent's $166M Nasdaq debut - The Business Journals
Can Nuvalent Inc. continue delivering strong returnsQuarterly Portfolio Report & Safe Capital Investment Plans - خودرو بانک
Guggenheim initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com Canada
Guggenheim initiates coverage on Nuvalent stock with Buy rating - Investing.com
How is Nuvalent Inc. managing supply chain issuesWeekly Stock Summary & Accurate Trade Setup Notifications - خودرو بانک
Can Nuvalent Inc. rally from current levelsIndex Update & AI Driven Stock Reports - Newser
Nuvalent Inc Azioni (NUVL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nuvalent Inc Azioni (NUVL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pelish Henry E. | Chief Scientific Officer |
Sep 10 '25 |
Sale |
78.83 |
3,725 |
293,642 |
65,963 |
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):